Ideal candidates for GLP-1 therapy, including Semaglutide and Tirzepatide treatments in NYC, are adults with a BMI of 27 or higher, particularly those with weight-related health issues
These rhythm-based protocols are designed to help users reinforce small wins, reduce all-or-nothing thinking, and avoid the common psychological traps that derail most weight loss efforts
The discovery of novel GLP-1 R agonists, which include orally bioavailable agonists, allosteric modulators, and multi-agonists, is noted in this review
Quesada O et al
These early observations helped guide continued treatment during later phases of the clinical studies
BPC-157 and TB-500 are two of the most discussed peptides in the regenerative and tissue-repair research space